| Q34184464 | A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma. |
| Q37507415 | An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. |
| Q64077318 | Analysis of potential key genes in very early hepatocellular carcinoma |
| Q90664270 | CDK1 dependent phosphorylation of hTERT contributes to cancer progression |
| Q77542057 | Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma |
| Q26784351 | Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis |
| Q36308149 | Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection |
| Q35182909 | Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma |
| Q38714300 | Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma |
| Q35011009 | Ibulocydine is a novel prodrug Cdk inhibitor that effectively induces apoptosis in hepatocellular carcinoma cells |
| Q54979784 | Identification and functional analysis of a core gene module associated with hepatitis C virus-induced human hepatocellular carcinoma progression. |
| Q33591504 | Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods |
| Q99617222 | Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data |
| Q39634765 | Impact of G₂ checkpoint defect on centromeric instability. |
| Q33494037 | Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin |
| Q73806599 | Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway |
| Q55306862 | Oleanolic acid induces p53-dependent apoptosis via the ERK/JNK/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice. |
| Q42783075 | Over-expression of p53, p21 and Cdc2 in histologically negative surgical margins is correlated with local recurrence of laryngeal squamous cell carcinoma |
| Q33317065 | Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo |
| Q35003431 | Overexpressions of Cyclin B1, cdc2, p16 and p53 in human breast cancer: the clinicopathologic correlations and prognostic implications |
| Q39767676 | Per2 inhibits k562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction |
| Q33672809 | Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis |
| Q37065279 | Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer |
| Q92839577 | Prognostic value of human papillomavirus infection and p53, p16, epidermal growth factor receptor and p34cdc2 expression in patients with salivary adenoid cystic carcinoma |
| Q33785608 | Protein signature for non-small cell lung cancer prognosis |
| Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
| Q35968417 | Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? |
| Q81301620 | Relationship between intracellular localization of p34cdc2 protein and differentiation of esophageal squamous cell carcinoma |
| Q41155017 | The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells. |
| Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
| Q73714783 | p34cdc2 expression is an independent indicator for lymph node metastasis in colorectal carcinoma |